| abstract |
The present invention relates to new pharmaceutical compositions comprising thienopyrimidine compounds according to formula (I). Furthermore, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and / or treatment of diseases that may be influenced by the inhibition of the kinase activity of Mnk1 and / or Mnk2 ( Mnk2a or Mnk2b) and / or variants thereof. (see formula (I)) where X is selected from CH or N. |